Medicox
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Medicox makes structural steel blocks used in shipbuilding and also produces electric motors and generators, including motors for railway vehicles, on an OEM (contract-manufacturing) basis for other companies.
It supplies shipbuilders and industrial customers, sitting in the supply chain as a components and sub-assembly provider. Listed on KOSDAQ, Korea's tech and small-cap exchange, the company operates across two distinct segments: a shipbuilding-parts division and an electric-motor and generator division.
Summary is AI-generated and may contain errors · figures from DART filings
Its railway-motor business is conducted via OEM supply to Hyundai Rotem and through Korea's national railway procurement process, making order flow dependent on government tenders.
Medicox in five facts
What does Medicox do?
Medicox makes structural steel blocks used in shipbuilding and also produces electric motors and generators, including motors for railway vehicles, on an OEM (contract-manufacturing) basis for other companies.
Where is Medicox listed and in which sector?
Medicox (Korean name: 메디콕스) trades under KRX code 054180 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Machinery.
How large is Medicox?
Its market capitalisation was US$9.6M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Medicox's latest annual revenue and operating profit?
For fiscal year 2025, Medicox reported revenue of US$21.3M, an operating loss of US$4.3M and a net loss of US$9M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was down 8.0% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- DisclosureOct 15
- Results of extraordinary shareholders' meetingOct 15
- Material event report (asset disposal)Oct 15
- Proxy solicitation reference documentOct 6
- Trading suspensionOct 1
- Other market noticeOct 1
- Other management matter (voluntary)Oct 1
- Trading suspension liftedSep 30
- [Amended] Resolution to convene a general shareholders' meeting (extraordinary meeting)Sep 30
- Other market noticeSep 30
- Notice of general shareholders' meetingSep 30
- DisclosureSep 23
- [Amended] DisclosureSep 23
- [Amended] Resolution to convene a general shareholders' meeting (extraordinary meeting)Sep 22
- DisclosureSep 17
- Change of CEOSep 10
- Other market noticeSep 7
- DisclosureSep 7
- Other market noticeSep 1
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Medicox reported consolidated results for FY2025: revenue of US$19.3M (−8% year on year), an operating loss of US$3.9M and a net loss of US$7.96M.
Earnings · Feb 9